These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7297544)

  • 21. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of phenylbutazone in man.
    Dieterle W; Faigle JW; Früh F; Mory H; Theoblad W; Alt KO; Richter WJ
    Arzneimittelforschung; 1976 Apr; 26(4):572-7. PubMed ID: 782467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH; Ruemmler R
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on a new paste preparation of phenylbutazone.
    Snow DH; Douglas TA
    Vet Rec; 1983 Jun; 112(26):602-7. PubMed ID: 6879988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral cimetidine on plasma concentrations of phenylbutazone in horses.
    Christensen JM; Blythe LL; Craig AM
    J Vet Pharmacol Ther; 1985 Dec; 8(4):404-12. PubMed ID: 4094031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of phenylbutazone preparations in the horse.
    Rose RJ; Kohnke JR; Baggot JD
    Equine Vet J; 1982 Jul; 14(3):234-7. PubMed ID: 7106088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies with phenylbutazone, oxyphenbutazone, and para-paradichloro phenylbutazone in horses.
    Gandal CP; Dayton PG; Weiner M; Perel JM
    Cornell Vet; 1969 Oct; 59(4):577-80. PubMed ID: 5389255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
    Sabaté D; Homedes J; Salichs M; Sust M; Monreal L
    Equine Vet J; 2009 Sep; 41(7):700-5. PubMed ID: 19927590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of feeding on the fate of orally administered phenylbutazone, trimethoprim and sulphadiazine in the horse.
    Bogan JA; Galbraith A; Baxter P; Ali NM; Marriner SE
    Vet Rec; 1984 Dec; 115(23):599-600. PubMed ID: 6523691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kinetics of anti-inflammatory drugs in serum and synovia of horses (author's transl)].
    Lehmann W; Wintzer HJ; Frey HH
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):218-20. PubMed ID: 7026207
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
    Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse.
    Sullivan M; Snow DH
    Vet Rec; 1982 Jun; 110(24):554-8. PubMed ID: 7112870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bioavailability of phenylbutazone in the horse.
    Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.